explore -WSS

explore

author：entertainment 2025-10-01 17:57:33 - browse：89941

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Investigation reveals sickle cell patients pressured into sterilizations

WSS

CDC: Cases of alpha

Behind warning on Apellis’s eye drug lies a conflict of interest

Citing H5N1 threat, CDC urges peak flu monitoring this summer

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

For longer

Stoke drug shows lower activity against childhood epilepsy

knowledge

explore

Wikipedia

Sports medicine is finally prioritizing gender equality

Investigation reveals sickle cell patients pressured into sterilizations

Supreme Court strikes down use of affirmative action

Cue Health, Covid

At least 13 dead in Texas as scorching temps continue

Biogen joins immunology wave with $1.15 billion acquisition of HI

Medical records are filled with copy

As the dark side of IVF slowly comes into focus, even more transparency is needed

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

explore

Liver decline slowed by off

Fentanyl is making it harder to start addiction treatment

Questions and answers about ramping up H5N1 bird flu vaccine

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Liver decline slowed by off

leisure time

focus

hotspot

hotspot